Pharmabiz43m
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz1h
Novartis Entresto US patent upheld by US Court of Appeals
Novartis, an innovative medicines company, announced that the company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto ...
Pharmabiz4h
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz4d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz4d
AIPPSPA urges Kerala DCA to carry out separate inspections at discount pharmacies to ensure quality of drugs
Expressing concerns over the quality of medicines sold through discount pharmacies in Kerala, the state president of the All India Public and Private Sector Pharmacists Association (AIPPSPA), ...
Pharmabiz3d
NPPA recalculates ceiling price of azithromycin 250 mg following review order
The National Pharmaceutical Pricing Authority (NPPA) has released the revised calculation sheet for the ceiling price of azithromycin 250 mg tablet following a review order from the Department of ...
Pharmabiz4d
KSRPO concerned over growing number of medical shops across the state
The Karnataka State Registered Pharmacists Organisation (KSRPO) has expressed its concern on the growing number of medical shops in the state which is leading to intense competition, affecting ...
Pharmabiz2d
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim and Synaffix B.V. (Synaffix), a Lonza company focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs ...
Pharmabiz3d
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy
Astellas Pharma Inc. announced the US Food and Drug Administration (FDA) accepted the revised supplemental New Drug Application (sNDA) for Izervay (avacincaptad pegol intravitreal solution) for the ...
Pharmabiz5d
Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours
Adcentrx Therapeutics (Adcentrx), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-threatening diseases, announced the first patient dosed in ...
Pharmabiz5d
Parliamentary panel asks government to increase product basket of JAKs to include TB, mental ailment drugs
The Parliamentary panel that looked into the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has recommended augmentation of the Jan Aushadhi Kendras (JAKs) to become ...
Pharmabiz2d
Seven research leaders awarded prestigious NIHR award
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...